×
About 19,273 results

ALLMedicine™ Pulmonary Hypertension Center

Research & Reviews  6,895 results

A Large Animal Model for Pulmonary Hypertension and Right Ventricular Failure: Left Pul...
https://doi.org/10.3791/62694
Journal of Visualized Experiments : JoVE; Ukita R, Stokes JW et. al.

Aug 3rd, 2021 - Decompensated right ventricular failure (RVF) in pulmonary hypertension (PH) is fatal, with limited medical treatment options. Developing and testing novel therapeutics for PH requires a clinically relevant large animal model of increased pulmonar...

A predictive model for dilated cardiomyopathy with pulmonary hypertension.
https://doi.org/10.1002/ehf2.13535
ESC Heart Failure; Liang J, Zhu R et. al.

Aug 3rd, 2021 - Dilated cardiomyopathy (DCM) is defined as a serious cardiac disorder caused by the presence of left ventricular dilatation and contractile dysfunction in the absence of severe coronary artery disease and abnormal loading conditions. The incidence...

Balloon Pulmonary Angioplasty in Chronic Totally Occluded Pulmonary Arteries: Applying ...
https://www.ncbi.nlm.nih.gov/pubmed/34338653
The Journal of Invasive Cardiology; Steinberg ZL, Lombardi WL et. al.

Aug 3rd, 2021 - This study aims to describe the safety and efficacy of revascularizing chronic total occlusions (CTOs) of the pulmonary arteries with balloon pulmonary angioplasty (BPA) in patients with chronic thromboembolic pulmonary hypertension (CTEPH). BPA h...

Heat shock protein 70 attenuates hypoxia‑induced apoptosis of pulmonary microvascular e...
https://doi.org/10.3892/mmr.2021.12327
Molecular Medicine Reports; Cao J, Yang L et. al.

Jul 31st, 2021 - Pulmonary microvascular endothelial cell (PMVEC) apoptosis is the initial stage of adult pulmonary hypertension (PH), which involves high pulmonary arterial pressure and pulmonary vascular remodeling. However, the mechanism regulating PMVEC apopto...

see more →

Guidelines  16 results

Management and Appropriate Use of Diazoxide in Infants and Children with Hyperinsulinism.
https://doi.org/10.1210/clinem/dgaa543
The Journal of Clinical Endocrinology and Metabolism; Brar PC, Heksch R et. al.

Aug 19th, 2020 - The diagnosis of hypoglycemia and the use of diazoxide have risen in the last decade. Diazoxide is the only Food and Drug Agency-approved pharmacologic treatment for neonatal hypoglycemia caused by hyperinsulinism (HI). Recent publications have hi...

Canadian Cardiovascular Society/Canadian Thoracic Society Position Statement on Pulmona...
https://doi.org/10.1016/j.cjca.2019.11.041
The Canadian Journal of Cardiology; Hirani N, Brunner NW et. al.

Jul 20th, 2020 - The landscape of pulmonary hypertension (PH) has changed significantly since the last Canadian Cardiovascular Society/Canadian Thoracic Society position statement in 2005. Since then, advances in our understanding of the pathophysiology of PH and ...

Canadian Cardiovascular Society/Canadian Cardiac Transplant Network Position Statement ...
https://doi.org/10.1016/j.cjca.2019.12.025
The Canadian Journal of Cardiology; Chih S, McDonald M et. al.

Mar 9th, 2020 - Significant practice-changing developments have occurred in the care of heart transplantation candidates and recipients over the past decade. This Canadian Cardiovascular Society/Canadian Cardiac Transplant Network Position Statement provides evid...

2019 updated consensus statement on the diagnosis and treatment of pediatric pulmonary ...
https://doi.org/10.1016/j.healun.2019.06.022
The Journal of Heart and Lung Transplantation : the Offic... Hansmann G, Koestenberger M et. al.

Sep 10th, 2019 - The European Pediatric Pulmonary Vascular Disease Network is a registered, non-profit organization that strives to define and develop effective, innovative diagnostic methods and treatment options in all forms of pediatric pulmonary hypertensive v...

Guidelines for the Treatment of Pulmonary Hypertension (JCS 2017/JPCPHS 2017).
https://doi.org/10.1253/circj.CJ-66-0158
Circulation Journal : Official Journal of the Japanese Ci... Fukuda K, Date H et. al.

Mar 12th, 2019 - Guidelines for the Treatment of Pulmonary Hypertension (JCS 2017/JPCPHS 2017).|2019|Fukuda K,Date H,Doi S,Fukumoto Y,Fukushima N,|therapy,

see more →

Drugs  38 results see all →

Clinicaltrials.gov  332 results

Secondary Pulmonary Hypertension in Adults With Sickle Cell Anemia
https://clinicaltrials.gov/ct2/show/NCT00011648

May 5th, 2020 - Sickle cell anemia is an autosomal recessive disorder and the most common genetic disease affecting African-Americans. Approximately 0.15% of African-Americans are homozygous for sickle cell disease, and 8% have sickle cell trait. Acute pain crisi...

Samples From Human Subjects to Facilitate Basic, Translational and Clinical Research
https://clinicaltrials.gov/ct2/show/NCT03253705

May 5th, 2020 - Our department is evaluating various aspects of the cardiovascular system and/or endothelial dysfunction and/or inflammation in disease states, such as, but not limited to, pulmonary hypertension (PH) and other pulmonary vascular diseases, arterio...

Taiwan Cohort - Chronic ThromboEmbolic Pulmonary Hypertension Registry
https://clinicaltrials.gov/ct2/show/NCT03667391

Apr 27th, 2020 - The diagnosis of chronic thromboembolic pulmonary hypertension (CTEPH) is difficult for numerous reasons and is related with a poor prognosis. In Taiwan, the incidence of CTEPH and its clinical features are unknown. This study aims at evaluating t...

Pulmonary Hypertension and Anastrozole Trial
https://clinicaltrials.gov/ct2/show/NCT03229499

Apr 24th, 2020 - The primary objectives of this study are to determine whether the study drug, anastrozole may improve six minute walk distance at six months compared to placebo and to assess safety and side effects up to twelve months in pulmonary arterial hypert...

A Dose Escalation Study to Assess the Safety and Efficacy of Pulsed Inhaled Nitric Oxide in Subjects With Pulmonary Fibrosis or Sarcoidosis
https://clinicaltrials.gov/ct2/show/NCT03727451

Apr 24th, 2020 - A phase 2b, open label study to assess the hemodynamic effects of increasing doses of pulsed, inhaled nitric oxide (iNO) in subjects with pulmonary hypertension associated with pulmonary fibrosis or sarcoidosis on long term oxygen therapy followed...

see more →

News  410 results

New AHA Statement Urges Attention to Sleep Apnea
https://www.medscape.com/viewarticle/953527?src=sapfe

Jun 22nd, 2021 - Obstructive sleep apnea (OSA) is common in patients with cardiovascular disease (CVD), yet it is often under-recognized and treated in cardiovascular practice, the American Heart Association (AHA) says in a new scientific statement. "Obstructive s...

Drug Candidate for Pulmonary Arterial Hypertension Identified
https://www.medscape.com/viewarticle/950946

May 12th, 2021 - NEW YORK (Reuters Health) - High-throughput screening combined with in silico bioinformatics analyses identified a compound that reversed blood vessel damage and halted lesion formation in a rat model of pulmonary arterial hypertension (PAH), and ...

Sjögren Syndrome-associated Interstitial Lung Disease Treated With Immunosuppression
https://www.medscape.com/viewarticle/948219?src=

Mar 30th, 2021 - This article originally appeared on Hospital for Special Surgery's website. Case Report A 39-year-old woman with former tobacco use (4.5 pack-years) presented with rapidly progressive interstitial lung disease (ILD). Two years prior, the patient d...

Global Registry Refines COVID-19 Risk in Adult Congenital HD 
https://www.medscape.com/viewarticle/948411

Mar 30th, 2021 - Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center. Most adults with congenital heart disease (CHD) do not face an increased risk of COVID-19 mortality, although certain subgroups remain at high risk, an internati...

Abuse of OTC Decongestant Potentially Deadly, FDA Warns
https://www.medscape.com/viewarticle/948125

Mar 25th, 2021 - Abuse or misuse of the over-the-counter (OTC) nasal decongestant propylhexedrine can cause serious harm that can lead to hospitalization, disability, or death, the US Food and Drug Administration (FDA) warns in a safety communication. "Major issue...

see more →

Patient Education  18 results see all →